Cite
HARVARD Citation
Bukkems, V. et al. (2021). A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV. CPT: pharmacometrics & systems pharmacology. pp. 161-172. [Online].